Oil prices will continue to fall, but don't expect shale production in the U.S. to slow down any time soon, Dennis Gartman told CNBC.» Read More
Providing insight on Bill Ackman and Valeant's proposed takeover of Allergan, with former SEC chairman Harvey Pitt and CNBC's Kate Kelly.
And it all has to do with how earnings are valued, the founder of the Vanguard group told CNBC.
CEOs and physical laborers should be closer in pay, former Minnesota Gov. Jesse Ventura told CNBC on Tuesday.
Providing instant analysis to Gilead and Amgen's quarterly numbers, with David Nelson, Belpointe Asset Management, and CNBC's Sharon Epperson and Kate Kelly.
Gilead is reporting Q1 EPS of $1.48 adj. on revenues of $5.00 billion, with CNBC's Meg Tirrell.
"Shark Tank" investor Kevin O'Leary discusses recent mergers between pharmaceutical companies.
Amgen is reporting Q1 EPS of $1.87 ex-items on revenues of $4.52 billion, with CNBC's Meg Tirrell.
AT&T is reporting Q1 EPS of $0.71 on revenue of $32.5 billion, with CNBC's Dominic Chu.
Stephen Wood, Russell Investments chief market strategist, and Terry Dolan, Benjamin & Jerold Brokerage CEO, discuss if the market is approaching a double top.
Discussing their investment strategies in this market rally, with Stephen Wood, Russell Investments chief market strategist, and Terry Dolan Benjamin & Jerold Brokerage CEO.
CNBC's Meg Tirrell previews the earnings of biotech players Gilead and Amgen. Tirrell explains why investors will be focusing on Gilead's Sovaldi sales.
Leslie Samuelrich, Green Century Capital Management president, explains how investors can capitalize in ways that are "green" and "friendly" to the environment and shares her best eco-friendly buys.
Jeffery Harte, Sandler O'Neill principal, weighs in on the recent turmoil at Citigroup, including fraud at its Mexican operations. CNBC's Kayla Tausche provides insight.
CNBC's Kayla Tausche reports from Citigroup's annual shareholder meeting where top shareholders faced executives for the first time since the bank failed the Fed's stress test.
Vanguard founder Jack Bogle, discusses long-term investing in equities and shares is thoughts on high-frequency trading.
Hedge fund manager David Einhorn has sent out Greenlight Capital's quarterly investor letter, reports CNBC's Dominic Chu.
Discussing the market rally and if a bigger pullback will strike, with Kenny Polcari, O'Neil Securities; Stephen Wood, Russell Investments, Chris Hobart, Hobart Financial Group; and Rob Morgan, V2V Associates.
CareerCast revealed their annual ranking of the 10 best and worst jobs for 2014. CNBC's Seema Mody reports.
With CareerCast naming the best and worst jobs for 2014, Lee LeCaptain, lumberjack, and Jerrod Ankenmen, mathematician, make the case for their professions.
Discussing Bill Ackman's partnership with Valeant to pursue a takeover of Allergan, with CNBC contributor Herb Greenberg and CNBC's Meg Tirrell.